Rationale for glycemic control in cardiac surgical patients: The portland diabetic project

Insulin

Volumn 1, Issue SUPPL. 1, 2006, Pages

  Furnary, Anthony P ^a  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DRUG COST; GLUCOSE BLOOD LEVEL; HEALTH CARE; HUMAN; HYPERGLYCEMIA; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LENGTH OF STAY; META ANALYSIS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK REDUCTION; SOCIOECONOMICS; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC REVIEW; UNITED STATES; WOUND INFECTION;

EID: 33749324162     PISSN: 15570843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-0843(06)80032-1     Document Type: Article

References (9)

1. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Proct. 10 Suppl 2 (2004) 21-33
2. Presentations made at:. Hyperglycemia cardiovascular disease, and hospitalized patient outcomes. Accessed March 30, 2006. Improving Control of Hyperglycemia Symposium (November 14, 2005) Accessed March 30, 2006
3. Lopaschuk G.D. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7 (2002) 149-159
4. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
5. The Society of Thoracic Surgeons STS National Database (2006)
6. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects. Crit Care Med. 33 (2005) 1624-1633
7. Cimochowski G.E., Harostock M.D., Brown R., Bernardi M., Alonzo N., and Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71 (2001) 1572-1578
8. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
9. American Heart Association. Available at: www.americanheart.org. Accessed April 4, 2006.